跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Riliz™ - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Riliz™
Approved
STANDARD
Riliz™
Haupt Pharma Münster GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fa667f606a8d38e4
Company
Haupt Pharma Münster GmbH
Type
Standard
Approval Details
Approval Id
fa667f606a8d38e4
Drug Approval Philippines Name
Riliz™
Product Name
Riliz™
Registration Number
DRP-11410
Brand Name
Riliz™
Generic Name
Dienogest
Dosage Form
Film-Coated Tablet
Dosage Strength
2 mg
Manufacturer
Haupt Pharma Münster GmbH
Importer
Unilab, Inc.
Distributor
Unilab, Inc.
Company Detail Path
/organization/haupt-pharma-munster-gmbh
Issuance Date
09 March 2022
Expiry Date
09 March 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fa667f606a8d38e4
Type
Standard
Back to Philippines FDA Approvals